The Designated Marketing Authorization Holder (DMAH) in Japan is responsible for obtaining and maintaining marketing approval for medical device and In-Vitro Diagnostic (IVD) products. They act as a liaison between the manufacturer and the Japanese regulatory authorities, overseeing the device or IVD’s compliance with Japanese regulations. DMAH ensures post-marketing surveillance, handles adverse event reporting, and supports recalls, if needed.